Stem cell trial for failing kidney transplants halted after safety issues
NCT ID NCT07005687
Summary
This study tested whether a patient's own bone marrow stem cells could help control chronic rejection in kidney transplant patients. It involved a very small group of patients who received the stem cell infusion after their standard anti-rejection treatment. The trial was stopped early because the rejection did not improve in any patient, and serious safety concerns arose in one case.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT REJECTION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.